We are live on ! Find out more
AFJKR

Aimei Health Technology Co Right
AFJKR

14 hedge funds and large institutions have $896K invested in Aimei Health Technology Co Right in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$223K
2
MP
Mangrove Partners
Connecticut
+$148K
3
HCM
Highbridge Capital Management
New York
+$128K
4
WAM
Wolverine Asset Management
Illinois
+$88K
5
CS
Clear Street
New York
+$79.4K

Top Sellers

No sellers this quarter

AFJKR Hedge Fund Activity: Q1 2024 in Review

14 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Right (AFJKR) for Q1 2024, worth a combined $896K.

Buyers outnumbered sellers: 14 funds opened new AFJKR positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Cowen and Company, opening a new position worth an estimated $223K.

  • 14 institutional investors held Aimei Health Technology Co Right (AFJKR) as of Q1 2024, up from 0 in Q4 2023.
  • Funds reported $896K of Aimei Health Technology Co Right stock for Q1 2024.
  • 14 funds opened new Aimei Health Technology Co Right positions in Q1 2024 and 0 closed out, a net change of +14 holders.
  • The largest Aimei Health Technology Co Right buyer in Q1 2024 was Cowen and Company, an estimated $223K added.

Based on aggregated 13F filings for Q1 2024.